Navigation Links
Visage Imaging Releases Amira 5.3
Date:7/19/2010

SAN DIEGO, Calif., July 19 /PRNewswire/ -- Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D and 4D biomedical data.

Amira's entirely new Neuro option contains a comprehensive set of tools for neuroscience research, specifically MR diffusion tensor imaging (DTI) as well as CT and MR brain perfusion imaging. The new option provides efficient calculation of perfusion results as well as analysis and display of multi-channel functional image data including gradients, tensors, and fiber tracking.

"With the new version of Amira, I finally get all the brain imaging tools I need, integrated in a single platform. The results from different modalities and functional calculations can be combined, processed, and presented together in very flexible ways – far superior to any other solution I know," says Prof. Dr. A. Brawanski, head of neurosurgery at the Regensburg University Hospital in Germany.

Furthermore, Amira 5.3 comes with a large number of new tools and improvements, such as DemoDirector, an easy-to-use graphical front end for creating animations and presentations using the popular DemoMaker module; a largely redesigned set of tools for spreadsheets and statistics; a number of enhancements to the popular FilamentEditor; and a full integration of the widely used Insight Segmentation and Registration Toolkit (ITK) into Amira's Developer Option.

"Amira 5.3 is the most powerful and reliable Amira ever – with hundreds of improvements and dozens of new modules and enhancements, designed in collaboration with leading research institutions all around the world. I am always impressed to see the level of activity and innovation in the ever-growing Amira community. Their contribution is what makes Amira so strong and so unique," says Dr. Hartmut Schirmacher, Director of Product Management for Visage Imaging.

Amira 5.3 is available for Windows 32 and 64 bit, Mac OS X, and Linux platforms. For more information, visit the product website www.amira.com.

Visage Imaging, Inc. – Visioneering Science for Life®

Visage Imaging is a global leading provider of scalable enterprise visualization, RIS and PACS solutions for clinical and preclinical imaging.  Targeted at hospitals and imaging centers of any size, the Visage products offer blazingly fast access to thin slice data anytime, anywhere, combined with a bi-directional RIS integration for a perfect workflow and a comprehensive set of clinical applications for all 2D, 3D and 4D interpretation and reporting, post-processing and image review tasks within and beyond radiology.  www.visageimaging.com

About Pro Medicus Limited

Pro Medicus Limited [ASX: PME] is Australia's leading medical IT and e-health provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. www.promedicus.com

Visage, Visage Imaging, and Visioneering Science for Life are registered trademarks of Pro Medicus Limited. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective holders.


'/>"/>
SOURCE Visage Imaging, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Visage Imaging Introduces Visage(R) 7 for Windows and Mac OS X
2. Visage Imaging Names John Danahy as General Manager North America, Sales and Services
3. Pro Medicus/Visage Imaging Signs Deal with Sydney-based Southern Radiology
4. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. Stereo Mammography Takes Breast Imaging to a New Dimension
8. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
9. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
10. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
11. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):